her3 as a new target in the oncology field
Published 10 years ago • 1.3K plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:45
her3 - a new therapeutic target mode of action animation
-
1:52
her3: survival pathway and therapeutic target in colorectal and pancreatic cancer | oncotarget
-
7:23
pay attention to the passenger: a new therapeutic target in cancer cell dna
-
51:24
her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
-
1:20:32
targeted therapy for her2 & her3-positive breast cancer: navigating the evolving treatment landscape
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
9:44
b7-h3: a promising new target in tumor immunotherapy
-
4:33
the her pathway and cancer
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
4:27
advancing her2 gc treatment
-
2:35
r3 comprehensive guide to stem cell and exosome therapy
-
1:07
prostate cancer vaccine
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
7:57
dr bhavesh poladia, patritumab deruxtecan her3 dxd in egfr mutated nsclc | crsf
-
2:53
a holistic, all-encompassing approach
-
2:45:10
targeted therapy for her2 and her3-positive breast cancer: navigating the evolving treatment landsca
-
1:10
dr. bunn on targeting her3 in nsclc
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
0:46
what does the future hold for adcs in breast cancer?
-
2:14
neratinib in her2 or her3 mutant solid tumours
-
5:35
case 2: treatment recommendations for er breast cancer
-
4:17
her2 inflammatory breast cancer: adjuvant strategies